FDA Warning Letter — Jubilant HollisterStier General Partnership
The FDA took a Warning Letter action against Jubilant HollisterStier General Partnership on Jun 5, 2026 (Kirkland, Canada). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Jubilant HollisterStier General Partnership
- Date
- Jun 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Kirkland (Canada)